Luspatercept’s use in a patient with transfusion-dependent
beta-thalassemia and intrathoracic extramedullary hematopoiesis (EMH).
- Mohammed Najdat Seijari
, - Awni Alshurafa,
- Mohamed Yassin
Mohammed Najdat Seijari

Hamad Medical Corporation
Corresponding Author:mseijari@hamad.qa
Author ProfileSubmitted to Clinical Case Reports 05 Mar 2024Review(s) Completed, Editorial Evaluation Pending
16 Mar 2024Editorial Decision: Accept